SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

246.67

56.43

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

Karur Vysya Bank standalone net profit rises 39.10% in the December 2025 quarter

Jan 23,2026

Net profit of Karur Vysya Bank rose 39.10% to Rs 689.96 crore in the quarter ended December 2025 as against Rs 496.03 crore during the previous quarter ended December 2024. Total Operating Income rose 12.28% to Rs 2794.18 crore in the quarter ended December 2025 as against Rs 2488.62 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Total Operating Income	2794.18	2488.62	12
OPM %	69.66	64.70	-
PBDT	900.57	667.83	35
PBT	900.57	667.83	35
NP	689.96	496.03	39

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,604.22 -63.41 (-0.59%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)